Synovus Financial’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.56M Buy
23,811
+762
+3% +$81.8K 0.03% 305
2025
Q1
$2.33M Buy
23,049
+5,602
+32% +$565K 0.03% 321
2024
Q4
$1.56M Sell
17,447
-71
-0.4% -$6.34K 0.02% 392
2024
Q3
$1.47M Buy
17,518
+1,167
+7% +$97.8K 0.02% 427
2024
Q2
$1.26M Sell
16,351
-35
-0.2% -$2.7K 0.02% 416
2024
Q1
$1.12M Sell
16,386
-232
-1% -$15.9K 0.01% 433
2023
Q4
$961K Buy
16,618
+418
+3% +$24.2K 0.01% 439
2023
Q3
$855K Buy
16,200
+10,226
+171% +$540K 0.01% 479
2023
Q2
$323K Buy
5,974
+32
+0.5% +$1.73K ﹤0.01% 710
2023
Q1
$297K Sell
5,942
-38
-0.6% -$1.9K ﹤0.01% 724
2022
Q4
$277K Buy
5,980
+14
+0.2% +$648 ﹤0.01% 750
2022
Q3
$230K Buy
5,966
+214
+4% +$8.25K ﹤0.01% 760
2022
Q2
$215K Buy
+5,752
New +$215K ﹤0.01% 791
2022
Q1
Sell
-5,752
Closed -$245K 848
2021
Q4
$245K Hold
5,752
﹤0.01% 787
2021
Q3
$249K Hold
5,752
﹤0.01% 766
2021
Q2
$245K Sell
5,752
-523
-8% -$22.3K ﹤0.01% 761
2021
Q1
$242K Sell
6,275
-3,667
-37% -$141K ﹤0.01% 691
2020
Q4
$357K Sell
9,942
-200
-2% -$7.18K ﹤0.01% 612
2020
Q3
$387K Sell
10,142
-160
-2% -$6.11K 0.01% 550
2020
Q2
$362K Sell
10,302
-7,457
-42% -$262K 0.01% 535
2020
Q1
$581K Buy
17,759
+7,700
+77% +$252K 0.01% 483
2019
Q4
$455K Buy
10,059
+341
+4% +$15.4K 0.01% 489
2019
Q3
$394K Buy
9,718
+1,486
+18% +$60.2K 0.01% 514
2019
Q2
$354K Buy
8,232
+2,361
+40% +$102K 0.01% 516
2019
Q1
$226K Hold
5,871
﹤0.01% 557
2018
Q4
$207K Buy
5,871
+871
+17% +$30.7K ﹤0.01% 557
2018
Q3
$191K Buy
5,000
+1,356
+37% +$51.8K ﹤0.01% 596
2018
Q2
$120K Buy
3,644
+40
+1% +$1.32K ﹤0.01% 652
2018
Q1
$99K Buy
+3,604
New +$99K ﹤0.01% 673
2017
Q2
Sell
-4,105
Closed -$102K 817
2017
Q1
$102K Sell
4,105
-127
-3% -$3.16K ﹤0.01% 627
2016
Q4
$92K Sell
4,232
-71
-2% -$1.54K ﹤0.01% 630
2016
Q3
$102K Buy
+4,303
New +$102K ﹤0.01% 603